首页 | 本学科首页   官方微博 | 高级检索  
检索        


A novel apoptosis-inducing monoclonal antibody (anti-LHK) against a cell surface antigen on colon cancer cells
Authors:Hidehiko Matsukawa  Takanori Kanai  Makoto Naganuma  Nobuhiko Kamada  Tadakazu Hisamatsu  Hiromasa Takaishi  Haruhiko Ogata  Makio Mukai  Hiromasa Ishii  Tsuneyo Mimori  Mamoru Watanabe  Toshifumi Hibi
Institution:(1) Department of Internal Medicine, School of Medicine, Keio University, Tokyo 160-8582, Japan;(2) Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan;(3) Department of Pathology, School of Medicine, Keio University, Tokyo, Japan;(4) Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Abstract:Background Apoptosis is a crucial element in the behavior of mammalian cells in many different situations. We here report the establishment of a novel monoclonal antibody (anti-LHK mAb) that has apoptosis-inducing activity against colon cancer Colo205 cells. Methods The mechanism of anti-LHK mAb-induced cell death was assessed by microscopic morphology, Annexin V/Hoechst 33528 staining, and detection of DNA fragmentation. The molecular weight of LHK antigen was determined by Western blotting. Growth inhibition of Colo205 cells induced by anti-LHK mAb was determined by in vitro and in vivo studies. Results Anti-LHK reacted with a 70-kDa antigen and completely blocked the proliferation of Colo205 cells bearing LHK in vitro in a manner characteristic of apoptosis. Strikingly, anti-LHK mAb suppressed tumor growth in a murine peritoneal dissemination model. Conclusions LHK antigen, which is restricted to epithelial cells, may be a novel death receptor that plays a critical role in controlling the growth, invasion, and metastasis of human colon cancer cells.
Keywords:anti-LHK mAb  apoptosis  Fas  colon cancer
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号